Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Semaglutide the original ~14.9% average body-weight reduction at 52 weeks Targets GLP-1 (one pathway) Weekly injection Best for: first-timers, or anyone sensitive to side effects Tirzepatide the upgrade ~22.1% average body-weight reduction at 52 weeks Targets GLP-1 + GIP (two pathways) Weekly injection Best for: plateaued on semaglutide, or want stronger results Retatrutide the newest ~25.9% average body-weight reduction at 52 weeks Targets GLP-1 + GIP + glucagon (three pathways) Weekly injection Best for: want the newest science, comfortable with a compounded option Semaglutide: the original Semaglutide is a GLP-1 receptor agonist
Where appropriate, Umbrella Labs can, upon request, provide additional reference information to support internal validation processes for non-clinical research
However, tretinoin can also cause peeling, redness, dryness, and temporary purging, especially when first starting treatment or using higher strengths
Additionally, patients with a history of bariatric surgery may already carry elevated hepatobiliary risk
Sterile water for injection does not contain the benzyl alcohol preservative, meaning bacteria can grow in the solution after the first puncture
